NDC 0143-9871

Cladribine

Cladribine

Cladribine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Cladribine.

Product ID0143-9871_d1115097-76ff-4f24-a8d5-bc0dc163e640
NDC0143-9871
Product TypeHuman Prescription Drug
Proprietary NameCladribine
Generic NameCladribine
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2000-02-28
Marketing CategoryANDA / ANDA
Application NumberANDA075405
Labeler NameHikma Pharmaceuticals USA Inc.
Substance NameCLADRIBINE
Active Ingredient Strength1 mg/mL
Pharm ClassesPurine Antimetabolite [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0143-9871-01

1 VIAL in 1 BOX, UNIT-DOSE (0143-9871-01) > 10 mL in 1 VIAL
Marketing Start Date2000-02-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0143-9871-01 [00143987101]

Cladribine INJECTION
Marketing CategoryANDA
Application NumberANDA075405
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2000-02-28

Drug Details

Active Ingredients

IngredientStrength
CLADRIBINE1 mg/mL

Pharmacological Class

  • Purine Antimetabolite [EPC]
  • Purine Antimetabolite [EPC]

NDC Crossover Matching brand name "Cladribine" or generic name "Cladribine"

NDCBrand NameGeneric Name
0143-9871CladribineCladribine
42658-010CladribineCladribine
63323-140CladribineCLADRIBINE
67457-450CladribineCladribine
44087-4000MavencladCladribine
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.